Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Amylyx Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
AMLX
Nasdaq
8731
https://www.amylyx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Amylyx Pharmaceuticals Inc
European study finds popular ALS drug ineffective
- Mar 27th, 2024 11:36 am
3 Pharma Stocks to Sell in March Before They Crash & Burn
- Mar 14th, 2024 10:49 pm
Biotech Stock Roundup: AMLX, ACAD Down on Study Data, MRNA, RGLS Gain on Updates & More
- Mar 14th, 2024 4:07 pm
Amylyx Pharmaceuticals Appoints Bernhardt Zeiher, MD, FCCP, FACP, to its Board of Directors
- Mar 14th, 2024 1:00 pm
Analysts on Wall Street Lower Ratings for These 10 Stocks
- Mar 13th, 2024 1:03 pm
After surprise trial failure, ALS doctors brace for one less treatment option
- Mar 12th, 2024 11:55 am
Amylyx's (AMLX) ALS Drug Fails Pivotal Study, Stock Down 82%
- Mar 11th, 2024 4:34 pm
Amylyx CEOs look for a path forward following major setback
- Mar 11th, 2024 11:45 am
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Analysts Are Reducing Their Forecasts For This Year
- Mar 10th, 2024 12:34 pm
Wall Street Predicted a Blockbuster. Now the Drug May Be Withdrawn.
- Mar 10th, 2024 12:00 pm
Amylyx Stock Wipes Out Nearly All Of Its Value, Crashing 82%, After Pivotal ALS Drug Failure
- Mar 8th, 2024 9:05 pm
Maker of much-debated ALS drug says it may stop selling it after study showed it didn't work
- Mar 8th, 2024 4:30 pm
Amylyx’s ALS Drug Fails Trial, Raising Questions About Company’s Future
- Mar 8th, 2024 3:20 pm
10 Biotech Stocks with Huge Potential
- Mar 8th, 2024 2:38 pm
Amylyx Pharmaceuticals Announces Topline Results From Global Phase 3 PHOENIX Trial of AMX0035 in ALS
- Mar 8th, 2024 12:00 pm
Amylyx ALS drug fails crucial study, putting company’s future in doubt
- Mar 8th, 2024 7:05 am
The Top 3 Biotech Stocks to Buy in March 2024
- Mar 6th, 2024 7:45 pm
7 Oversold Russell 2000 Stocks to Add to Your February Buy List
- Feb 25th, 2024 11:30 am
Do Its Financials Have Any Role To Play In Driving Amylyx Pharmaceuticals, Inc.'s (NASDAQ:AMLX) Stock Up Recently?
- Feb 24th, 2024 12:45 pm
Earnings Miss: Amylyx Pharmaceuticals, Inc. Missed EPS By 22% And Analysts Are Revising Their Forecasts
- Feb 24th, 2024 12:23 pm
Scroll